Evidence map›Paper›PMID 36526584›Full record

ArticleJournal of chemical information and modeling2023

Jörg Heider, Jonas Kilian, Aleksandra Garifulina, Steffen Hering, Thierry Langer, Thomas Seidel

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Automated pharmacophore hypothesis generator for SILCS-Pharm: ph4gen.Journal of computer-aided molecular design · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. CACHE Challenge #1: Docking with GNINA Is All You Need.Journal of chemical information and modeling · 2024
    Article
  6. Watermelon: setup and validation of anJournal of enzyme inhibition and medicinal chemistry · 2024
    Article
  7. Article
  8. Article
  9. Frontiers in chemistry · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jörg HeiderDepartment of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090Vienna, Austria.
Jonas KilianVienna Doctoral School of Pharmaceutical, Nutritional and Sport Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090Vienna, Austria.
Aleksandra GarifulinaDivision of Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090Vienna, Austria.
Steffen HeringDivision of Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090Vienna, Austria.
Thierry LangerDepartment of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090Vienna, Austria.ORCID 0000-0002-5242-1240
Thomas SeidelDepartment of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090Vienna, Austria.ORCID 0000-0002-9815-6577

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmacophore models are widely used as efficient virtual screening (VS) filters for the target-directed enrichment of large compound libraries. However, the generation of pharmacophore models that have the power to discriminate between active and inactive molecules traditionally requires structural information about ligand-target complexes or at the very least knowledge of one active ligand. The fact that the discovery of the first known active ligand of a newly investigated target represents a major hurdle at the beginning of every drug discovery project underscores the need for methods that are able to derive high-quality pharmacophore models even without the prior knowledge of any active ligand structures. In this work, we introduce a novel workflow, called

Indexed as

Drug DiscoveryPharmacophoreLigandsRetrospective StudiesWorkflowLigands

Identifiers

PMID36526584
PMCPMC9832483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.